Boris Boumajny

Title: **Innovator Profile: Boris Boumajny**

Introduction

Boris Boumajny is an accomplished inventor hailing from Northborough, MA, in the United States. With a focus on improving scientific methodologies, he has made significant contributions in the field of biochemistry, particularly in the analysis of glycosaminoglycans.

Latest Patents

Boris holds a patent titled "Methods of detecting glycosaminoglycans." This innovative patent outlines methodologies for distinguishing glycosaminoglycans from various other components in a sample. It utilizes size-exclusion chromatography with a mobile phase at a pH of 6.8 or lower, thereby enhancing the separation of glycosaminoglycans from proteins. The low pH setting leads to improved elution of less dispersed protein and glycosaminoglycan fractions, reducing overlaps between these components.

Career Highlights

Currently, Boris Boumajny is employed at Bioverativ Therapeutics Inc., where he leverages his expertise to push the boundaries of therapeutic innovations. His work revolves around methodologies that have the potential to advance the understanding and treatment of various biological conditions stemming from modifications of glycosaminoglycans.

Collaborations

Boris's journey is complemented by fruitful collaborations with colleagues such as Zoran Sosic and Andrew Blum. Together, they form a team dedicated to unlocking new insights in therapeutic research, enhancing the overall impact of their collective work at Bioverativ Therapeutics Inc.

Conclusion

Boris Boumajny's contributions to the scientific field through his patent on glycosaminoglycan detection signify a commendable advancement in biochemistry. His ongoing work at Bioverativ Therapeutics Inc., coupled with his collaborations, promises further innovations that may reshape the understanding of related biological processes.